Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund (CBRF-BRIF)
Stage 2: Strategic Review Committee
The members below reviewed applications for one or both of the following programs:
- Clinical Trials Fund Projects—Round 2
- Canada Biomedical Research Fund and Biosciences Research Infrastructure Fund—Stage 2
Chair
Karimah Es Sabar
Chief executive officer and general partner
Quark Venture LP
Canada
Members
Kristin Baetz
Dean, Faculty of Science
University of Calgary
Canada
Luis Barreto
President
Dr. Luis Barreto & Associates
Canada
Imogen Coe
Professor, Department of Chemistry and Biology, Faculty of Science
Toronto Metropolitan University
Canada
David Dolphin
Original vice-president, Technology Development
Quadra Logic Technologies
Professor emeritus
The University of British Columbia
Canada
Inès Holzbaur
Founder and managing partner
AmorChem
Canada
Mathew Fleury
Adjunct professor, Faculty of Health Sciences
Simon Fraser University
Canada
Kibret Mequanint
Professor, Department of Chemical and Biochemical Engineering
Professor, School of Biomedical Engineering
Western University
Canada
Nicole Redvers
Associate professor, Western Research Chair, and director of Indigenous Planetary Health
Western University
Canada
Council of Expert Advisors Cross-Appointee
Ingrid Abbott-Permell
President, Biosafety Consultant
Universal Biosafety, Inc.
Canada
Refer inquiries to the relevant funding organization. Do not contact Strategic Review Committee (SRC) members directly. SRC members will not share any information regarding the competition, review process or results.
Page details
- Date modified: